Novo Nordisk Pharmatech
Founded 1949
About Novo Nordisk Pharmatech
Novo Nordisk Pharmatech A/S is the leading worldwide supplier of products as recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the biopharmaceutical and pharmaceutical industries. We improve biopharmaceutical manufacturing by developing and supplying innovative products used in the manufacturing of biopharmaceuticals.
Company Facts
- Founded: 1949
- Legal name: Novo Nordisk Pharmatech A/S
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Website: https://novonordiskpharmatech.com/
- Phone: +45 5667 1000
Social Profiles
Canonical: https://fsome.com/organization/novo-nordisk-pharmatech-8312230 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.